FY27 Revenue Growth Target: 15-20% YoY
Expected to be at least 15-20% higher than FY26, driven by new acid chloride products entering higher volume production (one product growing from Rs 4 crore to Rs 15 crore revenue).
TRANSPEK / guidance tracker
Keep management guidance in view.
Transpek Industry · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
New Product Commercialization: Q3-Q4 FY27
One non-acid chloride product expected to generate small revenue by end of this quarter; second product commercialization by end of FY27. Annual revenue potential of Rs 50 crore per product.
Odisha Greenfield Capex: Rs 250 Crore Over 5-6 Years
Board decision expected by November 2026 pending feasibility approval. Construction 1.5-2 years post-approval; equipment lead times add further timeline. 4-5 year payback expected.
R&D Expansion: Doubling Team and Infrastructure
R&D team and infrastructure to be doubled in FY27. Multi-purpose pilot plant (4 streams, multiple chemistries) to be ready by February 2027 to accelerate scale-up from R&D to commercial production.